{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T15:00:30Z","timestamp":1742396430312,"version":"3.37.3"},"reference-count":51,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MU576\/19-1, KFO262"],"award-info":[{"award-number":["MU576\/19-1, KFO262"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2016.00046","type":"journal-article","created":{"date-parts":[[2016,3,7]],"date-time":"2016-03-07T03:14:59Z","timestamp":1457320499000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Quantitative Imaging of D-2-Hydroxyglutarate in Selected Histological Tissue Areas by a Novel Bioluminescence Technique"],"prefix":"10.3389","volume":"6","author":[{"given":"Nadine F.","family":"Voelxen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Walenta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Proescholdt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Dettmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Pusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Mueller-Klieser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","article-title":"An integrated genomic analysis of human glioblastoma multiforme","volume":"321","author":"Parsons","year":"2008","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00401-008-0455-2","article-title":"Analysis of the IDH1 codon 132 mutation in brain tumors","volume":"116","author":"Balss","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00401-009-0561-9","article-title":"Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas","volume":"118","author":"Hartmann","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","article-title":"IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication","volume":"28","author":"Paschka","year":"2010","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10014-012-0085-1","article-title":"Frequent IDH1\/2 mutations in intracranial chondrosarcoma: a possible diagnostic clue for its differentiation from chordoma","volume":"29","author":"Arai","year":"2012","journal-title":"Brain Tumor Pathol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1634\/theoncologist.2011-0386","article-title":"Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping","volume":"17","author":"Borger","year":"2012","journal-title":"Oncologist"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1182\/blood-2011-11-391748","article-title":"IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma","volume":"119","author":"Cairns","year":"2012","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/2051-5960-2-19","article-title":"D-2-Hydroxyglutarate producing neo-enzymatic activity inversely correlates with frequency of the type of isocitrate dehydrogenase 1 mutations found in glioma","volume":"2","author":"Pusch","year":"2014","journal-title":"Acta Neuropathol Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF02312516","article-title":"D-2-hydroxyglutaric aciduria: case report and biochemical studies","volume":"3","author":"Chalmers","year":"1980","journal-title":"J Inherit Metab Dis"},{"key":"B14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF02312543","article-title":"L-2-Hydroxyglutaric aciduria: an inborn error of metabolism?","volume":"3","author":"Duran","year":"1980","journal-title":"J Inherit Metab Dis"},{"key":"B15","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/humu.21197","article-title":"An overview of L-2-hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype-phenotype study","volume":"31","author":"Steenweg","year":"2010","journal-title":"Hum Mutat"},{"key":"B16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/427890","article-title":"Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria","volume":"76","author":"Struys","year":"2005","journal-title":"Am J Hum Genet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/bpa.12309","article-title":"2-Hydoxyglutarate: D\/Riving pathology in gLiomaS","volume":"25","author":"Wahl","year":"2015","journal-title":"Brain Pathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1172\/JCI71180","article-title":"MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis","volume":"124","author":"Terunuma","year":"2014","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","article-title":"Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities","volume":"3","author":"Cairns","year":"2013","journal-title":"Cancer Discov"},{"key":"B22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/496038a","article-title":"Cancer: a metabolic metamorphosis","volume":"496","author":"Krall","year":"2013","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1101\/gad.217406.113","article-title":"What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer","volume":"27","author":"Losman","year":"2013","journal-title":"Genes Dev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1007\/s11427-013-4549-2","article-title":"Metabolic alteration in tumorigenesis","volume":"56","author":"Yang","year":"2013","journal-title":"Sci China Life Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"B27","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","article-title":"Hypoxia induces production of L-2-hydroxyglutarate","volume":"22","author":"Intlekofer","year":"2015","journal-title":"Cell Metab"},{"key":"B28","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cmet.2015.06.009","article-title":"2-Hydroxyglutarate inhibits ATP synthase and mTOR signaling","volume":"22","author":"Fu","year":"2015","journal-title":"Cell Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1172\/JCI67229","article-title":"Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate","volume":"123","author":"Andronesi","year":"2013","journal-title":"J Clin Invest"},{"key":"B30","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1634\/theoncologist.2014-0266","article-title":"Diagnostic value of plasma and urinary 2-hydroxyglutarate to identify patients with isocitrate dehydrogenase-mutated glioma","volume":"20","author":"Lombardi","year":"2015","journal-title":"Oncologist"},{"key":"B31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1750-3639.2011.00506.x","article-title":"Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas chromatography\/mass spectrometry","volume":"22","author":"Sahm","year":"2012","journal-title":"Brain Pathol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ab.2015.04.017","article-title":"Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas","volume":"481","author":"Pichumani","year":"2015","journal-title":"Anal Biochem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"15217","DOI":"10.1038\/srep15217","article-title":"Sensitive determination of onco-metabolites of D- and L-2-hydroxyglutarate enantiomers by chiral derivatization combined with liquid chromatography\/mass spectrometry analysis","volume":"5","author":"Cheng","year":"2015","journal-title":"Sci Rep"},{"key":"B34","first-page":"177","article-title":"Chiral compounds as indicators of inherited metabolic disease. Simultaneous stereodifferentiation of lactic-, 2-hydroxyglutaric- and glyceric acid by enantioselective cGC","volume":"1","author":"Kaunzinger","year":"1996","journal-title":"Enantiomer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s00401-012-1060-y","article-title":"Enzymatic assay for quantitative analysis of (D)-2-hydroxyglutarate","volume":"124","author":"Balss","year":"2012","journal-title":"Acta Neuropathol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-1-4939-1059-5_9","article-title":"Localizing and quantifying metabolites in situ with luminometry: induced metabolic bioluminescence imaging (imBI)","volume":"90","author":"Walenta","year":"2014","journal-title":"Neuromethods"},{"key":"B37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/labinvest.3700493","article-title":"A bioluminescence technique for quantitative and structure-associated imaging of pyruvate","volume":"87","author":"Sattler","year":"2007","journal-title":"Lab Invest"},{"key":"B38","first-page":"409","article-title":"Correlation of high lactate levels in head and neck tumors with incidence of metastasis","volume":"150","author":"Walenta","year":"1997","journal-title":"Am J Pathol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S1389-0344(01)00107-1","article-title":"Metabolic mapping with bioluminescence: basic and clinical relevance","volume":"18","author":"Walenta","year":"2002","journal-title":"Biomol Eng"},{"key":"B40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1432-1033.1980.tb04590.x","article-title":"The reversible dehydration of (R)-2-hydroxyglutarate to (E)-glutaconate","volume":"106","author":"Buckel","year":"1980","journal-title":"Eur J Biochem"},{"key":"B41","first-page":"1164","article-title":"Tissue water content and nuclear magnetic resonance in normal and tumor tissues","volume":"35","author":"Kiricuta","year":"1975","journal-title":"Cancer Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/BF00157805","article-title":"Geographical mapping of metabolites in biological tissue with quantitative bioluminescence and single photon imaging","volume":"25","author":"Mueller-Klieser","year":"1993","journal-title":"Histochem J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.2174\/0929867043364711","article-title":"Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology","volume":"11","author":"Walenta","year":"2004","journal-title":"Curr Med Chem"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1039\/A806431H","article-title":"The catalysed NADH reduction of resazurin to resorufin","volume":"2","author":"Candeias","year":"1998","journal-title":"J Chem Soc Perkin Trans"},{"key":"B45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1046\/j.1365-313x.2002.01222.x","article-title":"Spatial analysis of plant metabolism: sucrose imaging within Vicia faba cotyledons reveals specific developmental patterns","volume":"29","author":"Borisjuk","year":"2002","journal-title":"Plant J"},{"key":"B46","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1177\/002215540004800409","article-title":"Metabolic imaging in multicellular spheroids of oncogene-transfected fibroblasts","volume":"48","author":"Walenta","year":"2000","journal-title":"J Histochem Cytochem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/01.ATV.19.4.950","article-title":"A bioluminescence method for the mapping of local ATP concentrations within the arterial wall, with potential to assess the in vivo situation","volume":"19","author":"Levin","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations","volume":"207","author":"Gross","year":"2010","journal-title":"J Exp Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3109\/10428194.2012.701009","article-title":"2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels","volume":"54","author":"Pollyea","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1073\/pnas.1019393108","article-title":"Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome","volume":"108","author":"Reitman","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B51","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ijc.26425","article-title":"2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1\/2 mutation status or tumor size","volume":"131","author":"Capper","year":"2012","journal-title":"Int J Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T03:46:51Z","timestamp":1498276011000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fonc.2016.00046\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,7]]},"references-count":51,"URL":"https:\/\/doi.org\/10.3389\/fonc.2016.00046","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2016,3,7]]}}}